Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04959019
Other study ID # IRB-300006833
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date July 21, 2021
Est. completion date March 31, 2026

Study information

Verified date February 2024
Source University of Alabama at Birmingham
Contact Anna Moyana, B.S.
Phone 1-205-975-8446
Email amoyana@uabmc.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine how effective a 6-week exercise program is for improving memory compared to a no-intervention control group, investigate the brain changes that may be responsible for memory improvements, and determine if the memory benefits and brain changes are retained 6 weeks after completing the exercise intervention in people with Idiopathic generalized epilepsy (IGE).


Description:

The primary objectives of this randomized controlled trial are to determine in adults with idiopathic generalized epilepsy (IGE) the efficacy of a 6-week supervised and structured exercise program combining endurance and resistance training for memory rehabilitation, investigate a putative mechanisms of action for exercise-related memory benefits, and determine if the memory benefits and brain changes are retained 6 weeks after completing the exercise intervention. Based on the investigators' pilot exercise data in adults with epilepsy, they hypothesize that exercise will significantly improve verbal memory function in the exercise group compared to the no-intervention control group. The investigators also hypothesize that the verbal memory improvements are mediated by the changes in resting state functional connectivity (rsFC) of the hippocampus, a brain region that plays a vital role in memory function. The investigators propose a mediation model in which exercise-induced changes in the hippocampus rsFC is mediating the beneficial effect of exercise on memory function in epilepsy, and will utilize the causal-steps approach in which 4 conditions of statistical significance must be met to determine if mediation is present.


Recruitment information / eligibility

Status Recruiting
Enrollment 114
Est. completion date March 31, 2026
Est. primary completion date December 31, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years to 55 Years
Eligibility Inclusion Criteria: - males and females - ages 18-55 years old - speaks English fluently - able to provide written informed consent - have no contraindications to 3-Telsa MRI - clinician-confirmed diagnosis of IGE (IGE includes epilepsy syndromes such as juvenile myoclonic epilepsy, juvenile absence epilepsy, childhood absence epilepsy, and generalized tonic-clonic seizures alone) - relatively healthy with no comorbid medical conditions besides epilepsy - normal pre-enrollment structural clinical MRI of the brain (if available) - no more than 4 seizure days/month in past 6 months - having less than the American Heart Association recommendation of physical activity in adults (at least 30 min moderate-intensity aerobic activity at least 5 days/week (150 min total), or at least 25 min vigorous aerobic activity at least 3 days/week (75 min total) and moderate-/high-intensity muscle strengthening activity at least 2 days/week) Exclusion Criteria: - underlying degenerative or metabolic disorders - abnormal general or neurological examination - abnormal brain MRI - recent suicidal ideation in the last 3 months determined based on previous medical history - pregnant or positive pregnancy test result on the day of the research session - contraindication to an MRI scan at 3-Telsa - mental handicap (FSIQ<80 if tested) or history of special education - >4 seizure days/month in past 6 months - concurrent participation in a different intervention study - diseased or enlarged heart or blood vessels determined based on previous medical history - high blood pressure that is not controlled by medications - meeting the American Heart Association recommendation of physical activity in adults - abnormal physical examination in which study physician determines subject should not participate in the exercise intervention

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Supervised combined endurance and resistance training (CERT)
Subjects will undergo up to 18 supervised sessions of a structured exercise program of combined endurance and resistance training (CERT). Supervised CERT will occur for 3 days/week, approx. 1 hr per session. Endurance training will start at 15 minutes and progress to 30 minutes of cycling on a stationary recumbent bicycle at 65-85% of heart rate reserve by week 3. Resistance training volume and intensity (baseline determined from strength tests) will progress over the first four sessions to 3 sets of 8-12 repetitions to volitional fatigue for 8 movements, with alternating upper-body and lower-body movements during the session. Progression will be incorporated throughout the trial for both endurance and resistance training to maintain relative intensity.
Delayed supervised combined endurance and resistance training (CERT)
After a 6-week delay period (no-exercise control), subjects will undergo up to 18 supervised sessions of a structured exercise program of combined endurance and resistance training (CERT). Supervised CERT will occur for 3 days/week, approx. 1 hr per session. Endurance training will start at 15 minutes and progress to 30 minutes of cycling on a stationary recumbent bicycle at 65-85% of heart rate reserve by week 3. Resistance training volume and intensity (baseline determined from strength tests) will progress over the first four sessions to 3 sets of 8-12 repetitions to volitional fatigue for 8 movements, with alternating upper-body and lower-body movements during the session. Progression will be incorporated throughout the trial for both endurance and resistance training to maintain relative intensity.

Locations

Country Name City State
United States University of Alabama at Birmingham Birmingham Alabama

Sponsors (1)

Lead Sponsor Collaborator
University of Alabama at Birmingham

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary estimated interaction effect between exercise group and visit for d' Repeated measures analysis of variance (rm-ANOVA) will be performed to examine condition-by-time interactions for our primary variable of interest, d', which is the discriminability index for delayed recognition memory on the California Verbal Learning Test - II (CVLT-II). Range is negative infinity to positive infinity for estimated interaction effect. 6 weeks after baseline
Primary estimated mediation effect of change in left hippocampus resting state functional connectivity (rsFC) in the effect of exercise on change in d' Regression tests of mediation for change in left hippocampus rsFC as the mediator variable in the effect of exercise on change in d' (from CVLT-II) will be performed using the causal-steps approach. The four steps in the causal process must be true for mediation to be present. Range is negative infinity to positive infinity for estimated mediation effect. 6 weeks after baseline
Secondary estimated interaction effect between exercise group and visit for Learning score Repeated measures analysis of variance (rm-ANOVA) will be performed to examine condition-by-time interactions for our secondary variable of interest, Learning score, which is the total words recalled immediately after the learning trials on the CVLT-II. Range is negative infinity to positive infinity for estimated interaction effect. 6-weeks after baseline
Secondary estimated interaction effect between exercise group and visit for Long Delay Free Recall score Repeated measures analysis of variance (rm-ANOVA) will be performed to examine condition-by-time interactions for our secondary variable of interest, Long Delay Free Recall score, which is the total words recalled 30 minutes after the learning trials on the CVLT-II. Range is negative infinity to positive infinity for estimated interaction effect. 6-weeks after baseline
Secondary estimated mediation effect of change in right hippocampus resting state functional connectivity (rsFC) in the effect of exercise on change in d' Regression tests of mediation for change in right hippocampus rsFC as the mediator variable in the effect of exercise on change in d' (from CVLT-II) will be performed using the causal-steps approach. The four steps in the causal process must be true for mediation to be present. Range is negative infinity to positive infinity for estimated mediation effect. 6-weeks after baseline
Secondary estimated interaction effect between exercise group and visit for Montreal Cognitive Assessment (MoCA) score Repeated measures analysis of variance (rm-ANOVA) will be performed to examine condition-by-time interactions for our secondary variable of interest, MoCA score, which is a measure of general cognitive functioning. Range is negative infinity to positive infinity for estimated interaction effect. 6-weeks after baseline
Secondary estimated interaction effect between exercise group and visit for Short-Form 36 (SF-36) physical component score Repeated measures analysis of variance (rm-ANOVA) will be performed to examine condition-by-time interactions for our secondary variable of interest, SF-36 physical component score, which is a quality of life subscale measure for physical health. Range is negative infinity to positive infinity for estimated interaction effect. 6-weeks after baseline
Secondary estimated interaction effect between exercise group and visit for Short-Form 36 (SF-36) mental component score Repeated measures analysis of variance (rm-ANOVA) will be performed to examine condition-by-time interactions for our secondary variable of interest, SF-36 mental component score, which is a quality of life subscale measure for mental health. Range is negative infinity to positive infinity for estimated interaction effect. 6-weeks after baseline
See also
  Status Clinical Trial Phase
Recruiting NCT03896529 - Neurobiological Mechanisms of Aging and Stress on Prospective Navigation N/A
Terminated NCT02331771 - Donepezil Memory Preservation Post ECT N/A
Recruiting NCT03268109 - COGnitive ImpairmenT in Older HIV-infected Patients ≥ 65 Years Old
Completed NCT00736034 - The Efficacy of Phosphatidylserine-Omega3 in Elderly Subjects With Memory Impairment Phase 4
Completed NCT04910399 - Development of an Innovative Health Ingredient From Marine By-products for the Healthy Aging N/A
Completed NCT02814526 - Exercise in Adults With Mild Memory Problems N/A
Recruiting NCT05289804 - Diminishing Accelerated Long-term Forgetting in Mild Cognitive Impairment Phase 1/Phase 2
Completed NCT04955457 - BDNF Promoter Methylation: Effects on Cognition, Stress and Anxiety and Depression Symptom in Healthy Women.
Completed NCT05033262 - Our Care Wishes - Dementia N/A
Recruiting NCT01919957 - Episodic Memory Before and After Surgery in Drug-resistant Partial Epilepsies N/A
Not yet recruiting NCT01708200 - A Comparison of the Effectiveness of Two Types of Memory Training Programs in People With a Diagnosis of Mental Illness. N/A
Recruiting NCT04583215 - Enhancing Frontal Lobes Plasticity in Mild Cognitive Impairment N/A
Recruiting NCT05543681 - IGC-AD1 Trial on Agitation in Dementia Due to Alzheimer's Phase 2
Active, not recruiting NCT03205709 - Cognitive Training and Neuroplasticity in Mild Cognitive Impairment N/A
Recruiting NCT02302482 - Predictive Factors and Autonomy Level Change N/A
Completed NCT02301247 - Treating New Learning and Memory Deficits in Progressive Multiple Sclerosis (MS) N/A
Completed NCT01708304 - Reducing Disabilities in Alzheimer's Disease (RDAD) Translation in Area Agencies on Aging (AAAs) N/A
Recruiting NCT06025877 - Quality Improvement and Clinical Utility PrecivityAD2(TM) Clinician Survey
Recruiting NCT05122598 - Development and Evaluation of Computerized Olfactory Training Program for Cognitive Decline in Early Alzheimer's Disease Phase 2
Completed NCT04473235 - Better Memory With Literacy Acquisition Later in Life N/A